The Molecular Targets of Swertiamarin and its Derivatives Confer Anti- Diabetic and Anti-Hyperlipidemic Effects

Publisher: Bentham Science Publishers

E-ISSN: 1873-5592|19|16|1958-1967

ISSN: 1389-4501

Source: Current Drug Targets, Vol.19, Iss.16, 2018-12, pp. : 1958-1967

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract